| Antigen | 16-aa peptide from Human GT111; (Gene Accession #Q9BYW1) Designation (GT111-P, control peptide /blocking peptide) conjugated to KLH; Epitope location~ C-terminal, Cytoplasmic domain |
| Form | Antiserum Unpurified |
| Product Type | Primary Antibodies |
| SpCrossreactivity | Human GT111-P peptide sequence has no significant sequence homology with other gluts. It has not yet been cloned from other species. Since the epitope for GT111-A is at the C-terminus, the antibodies should detect the long and short isoforms (Glut11-AB, or Glut11-C etc) that differs at the N-terminus or other regions. Antibody crossreactivity in various species is not established. Control peptide, because of its low mol. Wt (<3 kDa), is not suitable for Western. It should be used for ELISA or antibody blocking experiments (use 5-10 ug control peptide per 1 ug of aff pure IgG or 1 ul antiserum) to confirm antibody specificity |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |
